Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth in vivo, upon bevacizumab-induced hypoxia

Anna Golebiewska, Anais Oudin, Anne Steino, Simone Niclou, Dennis Brown, Jeffrey Bacha

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Pages90-90
DOIs
Publication statusPublished - Nov 2018
Event23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference - New Orleans, United States
Duration: 4 Nov 201818 Nov 2018

Conference

Conference23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference
Country/TerritoryUnited States
CityNew Orleans
Period4/11/1818/11/18

Cite this